Publications
Detailed Information
Significance of FLT3 ITD in CML progression and imatinib response : CML 진행과 imatinib 치료에서 FLT3 ITD 의의
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | 오정미 | - |
| dc.contributor.author | 김경임 | - |
| dc.date.accessioned | 2009-12-01T22:23:02Z | - |
| dc.date.available | 2009-12-01T22:23:02Z | - |
| dc.date.copyright | 2007. | - |
| dc.date.issued | 2007 | - |
| dc.identifier.uri | http://dcollection.snu.ac.kr:80/jsp/common/DcLoOrgPer.jsp?sItemId=000000045684 | eng |
| dc.identifier.uri | https://hdl.handle.net/10371/18085 | - |
| dc.description | Thesis(master`s)--서울대학교 대학원 :약학과 예방임상약학전공,2007. | en |
| dc.format.extent | v, 46 leaves | en |
| dc.language.iso | en | en |
| dc.publisher | 서울대학교 대학원 | en |
| dc.subject | 만성 골수성 백혈병 (CML) | en |
| dc.subject | chronic myelogenous leukemia (CML) | en |
| dc.subject | fms-like tyrosin kinase (FLT3) | en |
| dc.subject | fms-like tyrosine kinase(FLT3) | en |
| dc.subject | internal tandem duplication (ITD) | en |
| dc.subject | internal tandem duplication (ITD) | en |
| dc.subject | 예후 인자 | en |
| dc.subject | prognostic marker | en |
| dc.subject | imatinib mesylate | en |
| dc.subject | imatinib mesylate | en |
| dc.subject | 내성 | en |
| dc.subject | resistance | en |
| dc.title | Significance of FLT3 ITD in CML progression and imatinib response | en |
| dc.title.alternative | CML 진행과 imatinib 치료에서 FLT3 ITD 의의 | en |
| dc.type | Thesis | - |
| dc.contributor.department | 약학과 예방임상약학전공 | - |
| dc.description.degree | Master | en |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.